Dr. Fuad Makkouk , MD
Ophthalmology โข Austin, TX
9707 Anderson Mill Rd Ste 230
Austin, TX 787502300
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on May 14, 2013; this date does not establish years in practice.
-
Published CMS data list 201,546 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- J2403 โ Chloroprocaine hcl ophthalmic, 3% gel, 1 mg: 179,201 service units.
- J2777 โ Injection, faricimab-svoa, 0.1 mg: 18,960 service units.
- 92134 โ Imaging of retina: 1,090 service units.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPTยฎ only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 12 records in the table ยท Guide: How to read Medicare Part B data
-
Published CMS data list 201 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Prednisolone Acetate โ 52 prescription fills, including refills.
- Tobramycin-Dexamethasone (Tobramycin/Dexamethasone) โ 25 prescription fills, including refills.
- Latanoprost โ 21 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 9 records in the table ยท Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 95% of clinicians listed under Ophthalmology in Austin, TX (2024, 77 clinicians with data). Median for this group: 1,187. Middle half: 389 to 2,303.
More Medicare Part B services than 95% of clinicians listed under Ophthalmology in Texas (2024, 992 clinicians with data). Median for this group: 1,764. Middle half: 751 to 3,589.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 679 in 2020 to 201,546 in 2024.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2020โ2024.
Practice Location & Contact Primary Location
9707 Anderson Mill Rd Ste 230
Austin, TX 787502300
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
NPPES lists 3 distinct additional practice-address records in Austin, TX; Galveston, TX; New Haven, CT. See the list
Source: CMS NPPES NPI Registry, practice location records; release date unavailable.
CMS Doctors and Clinicians lists 1 group name: Texan Eye, Pa. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
University Of Texas Medical Branch At Galveston
2013
What Public CMS Data Show
Ophthalmology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
370 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider, 2024.
Medicare-allowed amount
About $1,165,758 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024.
Paid by Medicare
About $912,185 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024.
30-day fills
223 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$50,444 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $21,695.21 across 36 records.
By nature of payment (3 largest of 4)
- Consulting Fee: $17,495.00 across 4 records.
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program: $1,583.71 across 2 records.
- Travel and Lodging: $1,520.33 across 5 records.
Reporting-company totals (3 largest of 11)
- Boehringer Ingelheim Pharmaceuticals, Inc.: $14,415.04 across 10 records.
- Genentech, Inc.: $4,324.04 across 12 records.
- Boehringer Ingelheim International GmbH: $1,583.71 across 2 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
13 years (graduated 2013)
CMS Doctors and Clinicians data list 2013 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2013
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, โDoes your provider accept Medicare as full payment?โ
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Makkouk has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Makkouk as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Austin and Texas
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 95% of clinicians listed under Ophthalmology in Austin, TX (2024, 77 clinicians with data). Median for this group: 1,187. Middle half: 389 to 2,303.
More Medicare Part B services than 95% of clinicians listed under Ophthalmology in Texas (2024, 992 clinicians with data). Median for this group: 1,764. Middle half: 751 to 3,589.
Medicare-allowed amount
A higher Medicare-allowed amount than 80% of clinicians listed under Ophthalmology in Austin, TX (2024, 77 clinicians with data). Median for this group: $150,330. Middle half: $62,823 to $361,105.
A higher Medicare-allowed amount than 85% of clinicians listed under Ophthalmology in Texas (2024, 992 clinicians with data). Median for this group: $211,752. Middle half: $85,606 to $415,016.
Paid by Medicare
A higher Medicare payment amount than 80% of clinicians listed under Ophthalmology in Austin, TX (2024, 77 clinicians with data). Median for this group: $114,400. Middle half: $42,587 to $260,310.
A higher Medicare payment amount than 85% of clinicians listed under Ophthalmology in Texas (2024, 992 clinicians with data). Median for this group: $151,943. Middle half: $60,170 to $302,740.
Medicare Part D prescriptions
Fewer Part D prescriptions than 70% of clinicians listed under Ophthalmology in Austin, TX (2024, 82 clinicians with data). Median for this group: 340. Middle half: 163 to 900.
Fewer Part D prescriptions than 80% of clinicians listed under Ophthalmology in Texas (2024, 1,065 clinicians with data). Median for this group: 905. Middle half: 327 to 2,157.
Part D drug cost
Close to the middle for clinicians listed under Ophthalmology in Austin, TX (2024, 82 clinicians with data). Median for this group: $27,857. Middle half: $4,337 to $148,087.
Close to the middle for clinicians listed under Ophthalmology in Texas (2024, 1,065 clinicians with data). Median for this group: $73,797. Middle half: $14,089 to $240,265.
112 active clinicians are listed under Ophthalmology with a practice address in Austin, TX (1,517 in Texas).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Austin
0% of these 112 clinicians have the CMS telehealth indicator.
69.6% of these 112 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 29583% from 679 in 2020 to 201,546 in 2024.
- 2020: 679
- 2021: 941
- 2022: 1,524
- 2023: 10,761
- 2024: 201,546
-
Medicare-allowed amount
Medicare-allowed amount increased 2265% from $49,283 in 2020 to $1,165,758 in 2024.
- 2020: $49,283
- 2021: $178,571
- 2022: $327,220
- 2023: $600,054
- 2024: $1,165,758
-
Paid by Medicare
Paid by Medicare increased 2281% from $38,318 in 2020 to $912,185 in 2024.
- 2020: $38,318
- 2021: $138,704
- 2022: $253,310
- 2023: $465,605
- 2024: $912,185
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 230% from 61 in 2020 to 201 in 2024.
- 2020: 61
- 2021: 129
- 2022: 200
- 2023: 244
- 2024: 201
-
30-day fills
30-day fills increased 236% from 67 in 2020 to 223 in 2024.
- 2020: 67
- 2021: 176
- 2022: 219
- 2023: 256
- 2024: 223
-
Part D drug cost
Part D drug cost increased 2011% from $2,389 in 2020 to $50,444 in 2024.
- 2020: $2,389
- 2021: $35,602
- 2022: $88,463
- 2023: $135,222
- 2024: $50,444
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $494.53 in 2021 to $21,695.21 in 2025.
- 2021: $494.53
- 2022: $588.93
- 2023: $4,528.09
- 2024: $1,175.42
- 2025: $21,695.21
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo ยท Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 โ December 31, 2025): 36 records totaling $21,695.21.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Consulting Fee
Cash or cash equivalent
|
โ | General | $12,800.00 |
| Genentech, Inc. |
Consulting Fee
Cash or cash equivalent
|
Susvimo | General | $3,285.00 |
| Boehringer Ingelheim International GmbH |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
โ | General | $1,200.00 |
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Travel and Lodging
In-kind items and services
|
โ | General | $708.25 |
| Genentech, Inc. |
Consulting Fee
Cash or cash equivalent
|
Susvimo | General | $705.00 |
| Genentech, Inc. |
Consulting Fee
Cash or cash equivalent
|
Susvimo | General | $705.00 |
| Boehringer Ingelheim International GmbH |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
โ | General | $383.71 |
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Travel and Lodging
In-kind items and services
|
โ | General | $313.73 |
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Travel and Lodging
In-kind items and services
|
โ | General | $191.60 |
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Travel and Lodging
In-kind items and services
|
โ | General | $166.75 |
| Genentech, Inc. |
Food and Beverage
In-kind items and services
|
Susvimo | General | $143.29 |
| Alcon Vision LLC |
Food and Beverage
In-kind items and services
|
Centurion | General | $143.19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Travel and Lodging
In-kind items and services
|
โ | General | $140.00 |
| Apellis Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
Syfovre | General | $121.67 |
| Bausch & Lomb Americas Inc. |
Food and Beverage
In-kind items and services
|
enVista MX60 IOL | General | $107.91 |
| Genentech, Inc. |
Food and Beverage
In-kind items and services
|
Susvimo | General | $82.18 |
| BIOTISSUE HOLDINGS INC. |
Food and Beverage
In-kind items and services
|
โ | General | $63.89 |
| Genentech, Inc. |
Food and Beverage
In-kind items and services
|
Vabysmo | General | $58.71 |
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
โ | General | $35.00 |
| Harrow Eye, LLC |
Food and Beverage
In-kind items and services
|
TRIESENCE | General | $32.00 |
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
โ | General | $31.91 |
| Genentech, Inc. |
Food and Beverage
In-kind items and services
|
Susvimo | General | $28.91 |
| Astellas Pharma Global Development |
Food and Beverage
In-kind items and services
|
Izervay | General | $27.15 |
| Genentech, Inc. |
Food and Beverage
In-kind items and services
|
Vabysmo | General | $24.55 |
| Genentech, Inc. |
Food and Beverage
In-kind items and services
|
Vabysmo | General | $23.90 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPTยฎ is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016โ2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners โ by Provider and Service data, 2017โ2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
J2403
Chloroprocaine hcl ophthalmic, 3% gel, 1 mg
|
179,201 | 80 | $1.00 | $0.65 |
|
J2777
Injection, faricimab-svoa, 0.1 mg
|
18,960 | 67 | $50.00 | $34.50 |
|
92134
Imaging of retina
|
1,090 | 370 | $105.25 | $38.05 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
745 | 286 | $250.95 | $122.21 |
|
67028
Injection of drug into eye
|
418 | 102 | $231.68 | $113.63 |
|
G2211
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
|
305 | 172 | $35.18 | $15.75 |
|
92201
Extended exam of the back part of the eye with retinal drawing
|
260 | 227 | $35.73 | $23.41 |
|
J0178
Injection, aflibercept, 1 mg
|
200 | 32 | $1961.00 | $799.06 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
180 | 51 | $264.76 | $83.63 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
158 | 158 | $363.09 | $158.86 |
|
67145
Photocoagulation treatment to prevent detachment of retina
|
17 | 14 | $1222.02 | $216.02 |
|
99490
Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month
|
12 | 12 | $51.67 | $50.93 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Prednisolone Acetate | Prednisolone Acetate | 52 | 1,089 | $1,706.01 | 24 |
| Tobramycin-Dexamethasone | Tobramycin/Dexamethasone | 25 | 468 | $915.63 | 17 |
| Latanoprost | Latanoprost | 21 | 579 | $114.60 | โ |
| Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 21 | 249 | $267.25 | 18 |
| Atropine Sulfate | Atropine Sulfate | 20 | 1,172 | $596.98 | 17 |
| Difluprednate | Difluprednate | 19 | 367 | $1,029.20 | โ |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 17 | 330 | $268.35 | โ |
| Eylea | Aflibercept | 15 | 420 | $38,556.98 | โ |
| Restasis | Cyclosporine | 11 | 330 | $6,989.20 | โ |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2022-12-19NUCC Taxonomy Code: 207W00000X
An ophthalmologist has the knowledge and professional skills needed to provide comprehensive eye and vision care. Ophthalmologists are medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, an ophthalmologist prescribes vision services, including glasses and contact lenses.
NUCC Taxonomy Code: 207W00000X
An ophthalmologist has the knowledge and professional skills needed to provide comprehensive eye and vision care. Ophthalmologists are medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, an ophthalmologist prescribes vision services, including glasses and contact lenses.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - OPHTHALMOLOGY
I20191021000248
TX
0042580631
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Texan Eye, Pa
5717 Balcones Dr, Austin, TX 787314203
Phone: 5123277000
Secondary Practice Locations
9707 Anderson Mill Rd Ste 220
Austin, TX 78750
Phone: 5126939363
40 Temple St Ste 1b
New Haven, CT 065102715
Phone: 2037853360
700 University Blvd
Galveston, TX 77550
Phone: 4097475800
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 9707 ANDERSON MILL RD STE 230, AUSTIN, TX 787502300 (Tel: 5126939363)
Registered at 9707 ANDERSON MILL RD STE 230, AUSTIN, TX 787502300 (Tel: 5126939363)
Ophthalmology (license number reported to NPPES: CT 1.056429)
Recorded as FUAD MAKKOUK, MD
Ophthalmology (license number reported to NPPES: TX S0733)
Registered at 9707 ANDERSON MILL RD STE 220, AUSTIN, TX 78750 (Tel: 5126939363)
Registered at 9707 ANDERSON MILL RD STE 220, AUSTIN, TX 787500017 (Tel: 5126939363)
Ophthalmology (license number reported to NPPES: CT 1.056429)
Student in an Organized Health Care Education/Training Program
NPI status registered as active in NPPES database
Registered at 40 TEMPLE ST STE 1B, NEW HAVEN, CT 065102715 (Tel: (203) 785-3360)
Registered at 40 TEMPLE ST STE 1B, NEW HAVEN, CT 065102715 (Tel: (203) 785-3360)
Recorded as FUAD MAKKOUK
Ophthalmology (license number reported to NPPES: CT 1.056429)
NPI status registered as active in NPPES database
Registered at 700 UNIVERSITY BLVD, GALVESTON, TX 77550 (Tel: 4097475800)
Registered at 700 UNIVERSITY BLVD, GALVESTON, TX 77550 (Tel: 4097475800)
Recorded as FUAD MAKKOUK
Student in an Organized Health Care Education/Training Program
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Ophthalmology Specialists in Austin
- Dr. Rolake Alabi, MD PHD
- Dr. Aman Mittal, MD
- Dr. Nadja Torres, MD
- Dr. Charles Medert, MD
- Dr. Lan Hoang, MD
- Dr. Radha Ram, MD
More public profiles in Texas
Directory navigation, in NPI number order.
- Donald Hauser, MD Psychiatry & Neurology - Psychiatry ยท Bellaire
- Naeem Khan, MD Family Medicine ยท Amarillo
- Matthew Selmon, MD Internal Medicine - Interventional Cardiology ยท Austin
- Bogdan Chumak, MD Emergency Medicine ยท Abilene
- James Sutton, MD Internal Medicine ยท Garland
- Mahfuza Ahmed, MD Internal Medicine ยท Fort Worth
- Julie Dodd, MD Emergency Medicine ยท Austin
- Agbolade Odutayo, DO Emergency Medicine ยท Cameron
- John Sullivan, MD Radiology - Diagnostic Radiology ยท Plano
- Bennie Fore, MD Emergency Medicine - Emergency Medical Services ยท Bastrop
- Vijayachandran Nair, MD Internal Medicine ยท Cypress
- Obinna Chukwuocha, DO Family Medicine - Sports Medicine ยท Plano
Mailing Address
9707 Anderson Mill Rd Ste 230
Austin, TX 787502300
Phone: 5126939363